Spravato
Articles tagged with “Spravato”
CBT After Esketamine Cuts Relapse Risk, Trial Finds
The CBT-ENDURE trial found that pairing esketamine with 16 weeks of CBT reduced suicidal ideation and depression severity better than esketamine alone.
Ketamine Side Effects: What the Data Now Shows
New clinical guidance on NMDA antagonist side effects and discontinuation rates gives ketamine patients a clearer picture of what to expect and when to switch.
Ketamine vs. Esketamine: Side Effects and Who Stops Treatment
New clinical guidance on NMDA antagonist side effects and dropout rates helps patients make smarter choices about ketamine-based depression treatment.
Ketamine for TRD Works Better When Clinics Measure It
New research highlights how symptom tracking and dose optimization help treatment-resistant depression patients reach remission faster with ketamine.
Esketamine's Role in Treatment-Resistant Depression
Clinicians are turning to esketamine for TRD and suicidal depression. Here's what patients need to know about access, cost, and how it compares to IV ketamine.
Esketamine vs Racemic Ketamine: Understanding the Difference
A clinical comparison of esketamine (Spravato) and racemic ketamine, covering the S-enantiomer vs R/S mixture, FDA approval, efficacy data, cost, and practical considerations.
Racemic Ketamine vs Esketamine: Pharmacological Comparison
A detailed pharmacological comparison of racemic ketamine and esketamine (Spravato), covering efficacy, mechanisms, cost, access, and clinical decision-making.
Does Insurance Cover Ketamine Treatment?
A clear guide to insurance coverage for ketamine therapy, including Spravato, off-label IV infusions, and compounded formulations — plus tips for navigating coverage.
IV vs Oral vs Nasal Ketamine: Comparing Treatment Methods
A detailed comparison of IV infusion, oral/sublingual, and intranasal ketamine therapy methods covering effectiveness, cost, and convenience.
How Much Does Ketamine Therapy Cost?
A comprehensive breakdown of ketamine therapy costs by treatment type — IV infusion, Spravato, compounded formulations, and at-home options — plus factors that affect price.
Esketamine: The S-Enantiomer Behind Spravato
A glossary entry on esketamine, the S-enantiomer of ketamine marketed as Spravato, covering its pharmacology, FDA approval, and clinical significance.
FDA Esketamine (Spravato) Updates
A summary of the latest FDA regulatory actions, label updates, and clinical developments related to esketamine (Spravato) for depression treatment.
Ketamine Insurance Coverage: 2025 Trends and Developments
A look at the evolving insurance landscape for ketamine therapy in 2025, including Spravato coverage changes, off-label coverage, and what patients should know.
Intranasal Ketamine and Esketamine (Spravato)
A comprehensive guide to intranasal ketamine therapy, including the FDA-approved esketamine nasal spray Spravato — how it works, the REMS program, and clinical considerations.
Contact Ketamine Resource
Send corrections, partnership questions, or advertising inquiries.